Issue 105 • April 2021

Pharma enters the social media age

Preparing for the next pandemic

Long Covid and chronic fatigue

Big Tech meets
Big Pharma

What happens when two powerhouse industries combine forces to pursue innovation in healthcare?

In association with

02/23/2024 23:26:40
  • Home | Big Tech meets Big Pharma
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Proceedix
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Sanofi
  • ILC Dover
  • Nipro
  • ACG Worldwide
  • Comment
  • Covid-19 vaccine effectiveness affected by variants
  • Immuno-oncology high prescriber survey reveals top R&D strategies
  • Using methotrexate may reduce the negative impact of high treatment-related cost
  • Protecting against fake Covid-19 vaccines
  • Cytiva Company Insight
  • Cytiva
  • Datwyler Company Insight
  • Datwyler
  • In Depth
  • Is big pharma and big tech working together a recipe for success?
  • Logging in: how the pharma industry is getting to grips with social media
  • Medical cannabis: regulating a new export market on the Isle of Man
  • Long Covid: could chronic fatigue syndrome be taken seriously at last?
  • Life after Covid-19: four ways to prepare for the next pandemic
  • mRNA vaccines: the post-pandemic outlook after a breakthrough year
  • Staving off AMR disaster with Ineos and the University of Oxford
  • Public benefit: could the PBC model help pharma balance profits and patients?
  • The Solubility Company Insight
  • The Solubility company
  • Butterworth
  • Micronova
  • In Data
  • Inside the deal
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
03/17/2021 00:00:00